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Anticipating the Future of Biomedical Communications 
Meg White, Director, Technology Services, Rittenhouse Book Distributors 
Patricia Flatley Brennan, Director, National Library of Medicine 
The following is a transcript of a live presentation at 
the 2019 Charleston Conference. Video of this session 
is available at https://youtu.be/xxMpezF2sCo. 
Meg White: I’m up here on the stage and we said 
we were ready to go and the mics came live and the 
music went down, so, good afternoon and welcome. 
My name is Meg White and I’m here this afternoon 
to kick off our plenary session. 
A few housekeeping items: first, please silence all 
your cell phones and electronic devices. Just for your 
information, and Big Brother’s still listening, prob-
ably, the session is being recorded this afternoon. 
We’re going to endeavor to leave time for questions. 
Please use the microphones that are in the audience 
and please be sure to state your name and your 
affiliation when you ask a question. All right, well, 
I’m very pleased to be joined on the stage today by 
Dr. Patty Brennan. She is director of the National 
Library of Medicine. Dr. Brennan’s career and her 
background are extensive. She has a unique combi-
nation of engineering, information technology, and 
clinical care. Since being named director of the NLM 
in August 2016, Dr. Brennan has led the development 
of a strategic plan for the National Library of Medi-
cine and will speak to us today about the future of 
biomedical communication. Dr. Patty Brennan. 
Patricia Flatley Brennan: Good afternoon. You must 
be wondering what’s a medical library doing in this 
meeting today? Well, how many of you have had 
a health problem in the last 10 years? Okay. You 
need us. I will say not much more just yet, but I will 
tell you that the National Library of Medicine is the 
world’s largest biomedical library. We are a part of 
the National Institutes of Health. We have 1,700 
women and men that work together every day to 
bring you PubMed, MEDLINEplus, clinicaltrials.gov, 
and to conduct research and data science and in the 
application of biomedical informatics technologies 
to clinical data. I’m extremely proud to be a part 
of a federal library and I’m very delighted to be 
addressing this audience because I see intersections 
between the concerns of publishers, librarians, and 
federal libraries. We are not a lending library. We are 
a repository library. We do participate in interlibrary 
loan. We do have library cards still, by the way. You 
can get a library card to the National Library of Medi-
cine, but mostly we serve as a resource to the world. 
We provide the largest bibliographic repository, 
PubMed; many of you, I suspect, have run into that 
at one time or another. There are overall 30 million 
bibliographic citations in PubMed. We’re adding 
1 million a year. We also, though, as you look on the 
screen above you, have a number of other prod-
ucts that are important to the world. Our genomic 
repositories, our clinical variance, our dbGaP, these 
are data repositories that have billions of genomic 
sequences in them and I’m going to tell you some 
exciting news about those as we go forward. 
But we also provide information to communities. 
TOXNET provides important information about 
the environmental quality in a community. At 
clinicaltrials.gov a registry of clinical trials where 
patients who are worried and wondering can they 
find a treatment for complex illness can go there. 
DOCLINE is a way that we use to deliver biomedical 
knowledge to anyone who may need it anywhere in 
the world. WISER up in the right‐ hand corner is an 
in‐ the‐ moment smartphone‐ held application that 
gives specific toxic management information to first 
responders. 
We touch many lives, many places everywhere in the 
world, but we know that biomedical communications 
is changing and it is no longer your mother’s library. 
It can no longer be your mother’s library because we 
must keep pace with communication and serve the 
public. So, I’d like you to take a minute and watch 
a brief film that gives you our vision of where we 
think biomedical communications is going. (Video: 
Anticipating the Future of Biomedical Communica-
tion plays.) 
I’m very proud to be the director of an engine that 
powers data‐ driven discovery and data‐ powered 
health. We have just launched our strategic plan. Our 
10‐ year vision of what we will be doing is grounded 
in three key pillars: first, to accelerate discovery 
and advance health through data‐ driven research. 
Second, reach more people in more ways through 
enhanced dissemination and engagement; and third, 


















         
 






   
 
    
to prepare a workforce, including a citizen workforce, 
for data‐ driven research and health. We envision a 
future where a library becomes not just a building or 
a website but an ecosphere, as you see on the right‐ 
hand side, of interconnected digital research objects 
where literature, protocols, study data, funding 
opportunities, pipeline and pathways for genomic 
and assessments all are interconnected in the library 
sweet spot, as many of you know, is in structuring 
underneath each of those ovals and in building the 
interconnections between them. 
I’m going to talk with you for the next 20 minutes or
so about what the National Library of Medicine is
doing to support biomedical communications in the
21st century and I’m going to explain, address three
key aspects. First of all, improving the usability and
access to the research literature. Our sweet spot,
our strong point in the National Library of Medicine
as a part of the NIH is to bring research knowledge
together for the world. Second, to promote open
science and data sharing; and third, to guide 21st‐ 
century scientific communication. Now, the National
Library of Medicine is almost 300 years old and we’re
preparing for this through many conversations around
the world. What we began and we will continue to
be is fundamentally a collection, but our collection is
changing, and I heard some marvelous models this
morning about the new collection. We have been
custodians. People think of a library as a place that 
holds things and certainly preservation for the future
for future access is a critical role of the library, but
increasingly we connect to our connections and in the
future we have to focus on discovery on the fly and, as
I heard this morning, building new collections based
on the patterns of those discoveries. The National
Library of Medicine is primarily bringing literature and
knowledge and data into the hands of those who need
this, but we need to improve the usability and access
to the research literature.
This is our interface to PubMed. I suspect many 
of you have looked at PubMed for your patrons, 
for yourselves, maybe for someone in your family. 
PubMed is an amazing resource: 30+ million articles, 
two and a half million daily users, two and a half 
million users every day, most of them not coming 
to our building, by the way, coming to us electron-
ically. About 3 million searches and 9 million page 
views, but what we know is that 80% of the searches 
that are done on PubMed have more than one 
page of search results done and 90% of the people 
who search PubMed never go to the second page. 
So, if the article that you need or the article that 
you’ve published is on page 2, you’re dead. We are 
now committed to improving search and improv-
ing retrieval by artificial intelligence and machine 
learning approaches. We want to first and foremost 
improve the search quality, make sure we bring the 
most highly relevant resources in an efficient man-
ner to our users. But, second, we need to improve 
usability. So, what we are doing is adopting, out of 
the research from some of our intramural research-
ers, what we refer to as a learning to rank algorithm. 
Let me walk you through the diagram on the screen 
for just a moment. On the left‐ hand side you see our 
30 million citations, always in partnership with the 
publishers in an XML format, that are tagged with 
keywords, maybe, and then have human indexing 
applying the MeSH terminology to make the meta-
data useful for search, but we also are now tagging it 
with experience information, how often was this par-
ticular citation pulled up, for example, or what other 
citations were pulled up with this one. An individual 
launches a query at step one. That query is exploded 
through our PubMed interface and a set of series 
of what we call hits/matches are drawn up, mostly 
running about in the area of between 500 and 2,000 
site hits for each one. We need to sort them better. 
Currently we present them in reverse chronological 
order. That’s not enough. We also, from that zone, 
then in step three apply our new AI algorithm to 
the first 500 certain hit search returns. The first 500 
results are then resorted to create a best match of 
what the user has learned, is looking for, and then 
from that we monitor experience data, how often 
are those units searched on, how often are they 
clicked through, to make sure we’re actually improv-
ing our algorithm and have ways to lead experience 
into improvement. 
So, here’s what is returned to an individual now. If 
you look at this screen, this is a standard PubMed 
search screen. On the right‐ hand side you see a 
green box that has best match or most recent. We 
currently return most recent searches, but we are 
getting the community ready for the fact that we 
have this best match algorithm available so the red 
box that you see in the center alerts the user to 
some other articles that they may not find on the 
first page. Here’s our best match. Here’s what we 
think might be useful to you. Beginning in about 
90 days our default search will be the best match 
search, although you will be able to always get 
reverse chronological order searches returned. 
Here’s what our new interface is going to look like. 
There’s three things I want to call your attention to 
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 here. First, again, look in the upper right‐ hand cor-
ner. You may toggle between best match and reverse 
chronological order but, second, each of our citations 
now has a small series of phrases underneath it. We 
call these “snippets” that show the match to your 
search phrase so that you don’t have to click through 
to read an abstract to determine whether or not 
you want a particular article. On the left‐ hand side 
you see a histogram. There’s a slider bar underneath 
that histogram. It’s a reflection of how many articles 
per year were published in that according to that 
topic that you requested. You’re able to constrain 
your search to certain periods of time, thus allowing 
the user to have a better experience with PubMed. 
We’re excited about this. You can see this today, 
actually, if you Google PubMed Labs but we believe 
we’ll be going live in about 90 days for this. We are 
still open to your input. 
Now, the world is moving toward data and the world 
is moving toward openness. That is not a surprise 
to the audience here. I want to talk to you a little 
bit about what the National Library of Medicine is 
doing to improve and promote open science and 
data sharing. First and foremost, in our PubMed 
Central literature repository we hold the full text of 
over 5 million articles, most of them from federally 
funded research or historically valuable articles. 
These are freely available. About half of them are 
available for machine processing and the other half 
are available downloadable for human reading. 
Within this PubMed Central repository now, though, 
we are able to link data sets directly to articles so the 
data in support of an article can be made available to 
an individual. We have two key repositories: our cita-
tion repository, PubMed, and our full‐ text literature 
repository, PubMed Central. Each of these provides 
a pathway to data. Within PubMed, our citation 
repository, we make link outs to Figshare, we make 
link outs to various public data repositories as you 
see on the left side. Within PubMed Central we have 
data citations and other supplementary material 
connected directly to the article. We know this is 
not the final solution, but it’s now a pathway to get 
direct access to data. It’s been a bit of an experiment 
to get our researchers to curate their own data. I will 
tell you they need a little help with this. Libraries 
have lots of work to do in the future. Almost all of 
what I’ve described to you so far is housed at the 
National Library of Medicine and can be downloaded 
by an individual through our FTP sites or through 
industries that we also have partnerships with, but 
our genomic databases are growing so rapidly that 
the download is becoming impossible to support, 
so we have recently started to move some of our 
high‐ valued genomic data sets into cloud instances, 
into commercial cloud storage within Amazon, AWS, 
and Google Cloud. We have—the first repository 
we launched was the Sequence Read Archive. The 
Sequence Read Archive is about a 12 PB repository of 
annotated sequences, genomic sequences that are 
now available that can be interrogated and operated 
on in cloud instances. We are also in the process 
of modifying our search and analysis algorithms 
including the blast algorithm, which is a sequence 
alignment algorithm to make these possible to run 
in cloud instances. Those of you who have started 
to migrate into cloud instances know it’s not merely 
a matter of lift and shift. You have to restructure 
things, you have to find new pathways in. Funda-
mentally, we are committed to making data accessi-
ble, and clinical data are accessible through the fast 
interoperability—fast health care interoperability 
resource. This is one step we are taking toward the 
goal of making all data findable, accessible, inter‐
operable, and reusable. 
Now, I’ve talked to you about literature; I’ve talked 
to you about data. But what brings knowledge out of 
data are the analytical tools, the models we apply to 
data. The National Library of Medicine is questioning 
how do we build a library of models? What charac-
teristics? What is the grammar for models? What 
are the metadata for artificial intelligence models 
or machine‐ learning algorithms? We are beginning 
to explore how to code and document and make 
accessible the analytical tools that one can use to 
operate on our resources. We believe that models 
must be described by key metadata or data elements 
including the type, the purpose, the assumptions 
built, when it was made, and also most importantly, 
what was the intended use and can this model scale? 
Building analytical models takes millions of dollars of 
research investments and if they’re only useful for 
solving one problem, we’ve wasted federal dol-
lars, so we need to know how do we make models 
scalable and when do we do that? That is a process 
of model verification and validation, and the library 
is becoming a partner with scientists and method-
ologists around the world to be able to make this 
happen. 
But we are deeply in a period of change and I’m 
bringing the library along to improve the discover-
ability of the biomedical literature and through the 
literature data and through the “data to models.” 
I’m happy to be saying today we’re announcing the 
launch of MEDLINE 2022. Those of you who have 
Charleston Conference Proceedings 2019  23 
been involved in the library know we have been 
quietly working on this for a while. MEDLINE 2022 is 
an approach to make our literature more available 
more quickly in a way that will accelerate scientific 
discovery. We are focusing on three key areas: first, 
curation at scale; second, expanding metadata; 
and third, creating strategies that are efficient and 
connected. Our activities for creation at scale are 
all targeted toward that upper right‐ hand corner. 
Having a citation indexed within 24 hours of being 
deposited. We cannot do this without partnership 
with the publishers. We recognize that your ability 
to send us XML and properly tagged articles allows 
us to accelerate our indexing strategy. We must also 
recognize that human curation, a very expensive 
effort, a very important effort, has to be preserved 
for those articles most in need of that. Second, to 
develop expanded metadata. We are focusing on 
optimizing metadata to support interconnectedness 
across our various resources and registry. We are 
focusing also on expanding the use of funders’ meta-
data in our literature services. We heard this morn-
ing how important the funders are in open access 
and open data sharing. We need to make sure we 
have a way to support the funders in looking at and 
evaluating the impact of their resources. And finally, 
our emphasis on creating things in an efficient and 
connected way. We are enhancing the MeSH vocabu-
lary. We’re working on adding authoritative vocabu-
laries to MeSH to increase it, and MeSH, by the way, 
I’m sorry, is a medical subject heading. I apologize for 
talking federal jargon in front of you. This is the most 
essential terminology that we use to do our indexing 
and metadata. 
The last advance I want to talk to you about today I 
think might be the most commercial and I’m quite 
interested in your reactions to this. The National 
Library of Medicine, in cooperation with the National 
Institutes of Health, wants to increase the discov-
erability and use of preprints as part of biomedical 
scientific communication. We’re announcing the 
beginning of a pilot for examining preprints and 
making them accessible through our existing citation 
repositories and literature databases. The National 
Library of Medicine preprint pilot has as its goal 
to improve the discoverability of preprints, which 
downstream should accelerate discovery in science 
and, frankly, make science more efficient so we’re 
not replicating studies that are already done, which 
is a waste of federal dollars. In order to make this 
happen, certain conditions have to be made. The 
preprint gets deposited into a preprint server. The 
preprint is then shipped to the PubMed Central, our 
repository literature database, and an associated 
bibliographic citation is made in PubMed. All of the 
records of the preprints will be clearly marked as the 
material has not been peer‐ reviewed. It’s critical that 
our readers understand this. Our experiment is lim-
ited to NIH‐ funded research or preprints coming out 
of NIH‐ funded research. The preprints must be fully 
available in an XML markup. That’s the responsibility 
of the preprint service and the repository must have 
a license that allows for the inclusion of that par-
ticular document into a noncommercial repository. 
So, our plan is in partnership with existing preprint 
services that we will make their materials more dis-
coverable through our interface. 
The experiment is designed to accelerate scientific 
output of NIH funding. Clearly, that’s what we’re 
interested in. The National Library of Medicine is part 
of an enterprise that spends almost $40 billion a year 
of tax money to bring health to society. We must be 
good stewards of that. NIH recently has been encour-
aging, but not requiring, its investigators to use 
preprints in the service of conveying their informa-
tion and the results of their research early. We have 
a public access policy that requires that all archival 
articles supported by NIH be made freely available to 
the public in short periods of time, but we want to 
encourage investigators to start using preprint repos-
itories that can accelerate access to the information 
that they have available and fundamentally that 
help us to support the guidance that NIH is giving 
to our researchers of how to communicate. Now, in 
this era of publication we know scientists have many 
choices of where to put their articles. The National 
Institutes of Health remains committed to expand-
ing access to the scientific literature, but we want 
to do that in a way that it maintains the integrity of 
the scientific literature and yet, as a federal body, 
we do not give direct advice of which journals are 
acceptable to publish and which are not acceptable 
to publish and we do not maintain a whitelist or a 
blacklist, but rather the NIH has released guidance to 
its community to say that our publication policy is to 
look for journals, look for outlets that have rigorous 
editorial policies, have clearly defined ethics, have 
an emphasis on communicating in a scholarly way to 
the public. The National Library of Medicine is com-
mitted to working with partnerships. As we develop 
the preprint experiment it is absolutely essential that 
we maintain a relationship with the preprint service. 
We will not become a publisher. We will not become 
a preprint service on our own. As you notice, the 
preprint services that we are willing to partner with 
have the same criteria of good publication criteria 
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that NIH has listed that we need to use—have appro-
priate licensing, there must be rigorous transparent 
policies and practices to address plagiarism, com-
peting interests, misconduct; and fundamentally 
the preprint service itself must maintain accurate 
records for the preprints and allow us to have a way 
to coordinate, that is, to align archival publications 
with various forms of preprint activity, including the 
development of and increasing expanding use of 
open peer review. 
The National Library of Medicine is and will continue
to be a trusted source of health information. We
do not produce the information. We do not publish
the information but we facilitate the access to that
information. Participation in the National Library
of Medicine’s experiments with PubMed, our new
interface, our experiments with the preprint service,
and our use of our new and improved MEDLINE 2022
indexing strategies we hope will increase the acces-
sibility of trustable health information to the public
at large. We recognize that in an era of machine
learning, machine engagement, artificial intelligence,
the concept of trust must move beyond a human
level of developing an interpersonal agreement of
what trusted information is to computable machine/ 
machine interfaces that remain trustable and private.
As a library, we are committed to the values of library
science, which indicate full, unfettered access to
health information in a way that is unsupervised with-
out unnecessary oversight so that the examination
of ideas, the examination of science to create new
ideas becomes a tool that is useful for accelerating
science everywhere in the world. I thank you for the
opportunity to talk with you about how our focus on
improving biomedical science communications will
accelerate health for all and I’m ready to hear your
comments and questions. Thank you very much. 
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